Enzyre
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $12M
Investors
- 5
About Enzyre
V. provides blood coagulation management technology. As of 2022, the company is headed by Guido Maertens. The company offers a healthcare platform that engages in developing a device that could approach hemophilia patients. It offers a product called ENZYPAD which is a handheld micro-laboratory that helps in monitoring the blood coagulation status of any patient anywhere. The ENZYPAD processors carry ENZYCARDs which are small microfluidic cartridges that contain all the reagents and controls to perform up to sixteen reactions.
Who invested in Enzyre
5 investors across 1 round
See all investors in Enzyre
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 2, 2022
Amount
$12M
Investors
Questions about Enzyre
Who invested in Enzyre?
Enzyre has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enzyre raised?
Enzyre has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enzyre last raise money?
Enzyre's most recent round on record is a Series A, in Nov 2022.
What does Enzyre do?
Enzyre is a medical devices & equipment company.
Where is Enzyre headquartered?
Enzyre is headquartered in Netherlands.
Which VCs invest in companies like Enzyre?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Enzyre's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Enzyre? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.